Horizon Discovery

NEWS IN BRIEF

Glenmark opts for Horizon’s gene edited cell lines

01-Oct-2019 By Ben Hargreaves

Glenmark signs a full commercial license to utilize Horizon’s gene edited CHO cell lines to be added to the former’s biomanufacturing process.

Batavia eyes Horizon CHO cell tech to develop anti-Zika antibody

03-Sep-2019 By Melissa Fassbender

Batavia Biosciences signs a license agreement to use Horizon Discovery’s cell line expression system to produce a Zika virus-neutralizing antibody.

Ph I CAR-T cell therapy trial to use Horizon Discovery tech

08-Jul-2019 By Melissa Fassbender

The Phase I clinical trial is slated for early 2020 and will be first CAR-T cell therapy clinical trial to use Horizon Discovery’s technology, according to the company.

Horizon Discovery teams with UK hospital, EMQN to develop NIPT reference material

01-Apr-2019 By Melissa Fassbender

Horizon Discovery is working with St George’s University Hospital and EMQN to develop reference material for non-invasive prenatal testing, which is being increasingly adopted in the UK and abroad.

Horizon developing new CRISPR-based screening tech platform

30-Aug-2018 By Melissa Fassbender

Horizon Discovery is collaborating with a global pharmaceutical company to develop and apply single cell RNAseq-linked pooled CRISPR screening.